Healthcare // Browsing posts in Healthcare
Aurinia’s Lupkynis Gaining Traction and Generating High Interest (AUPH)
Research Question: Are Aurinia’s Lupkynis and GSK’s Benlysta for the treatment of LN gaining traction? Are they challenging the standard of care? Is one performing better than the other? Is there a place for both? Companies: AUPH, AZN, GSK By: David Franklin Click here to download report (.pdf) Summary of Findings In this update […]
Exact Sciences Idea Proposal (EXAS)
Will Exact Sciences experience growth by nearly doubling its Cologuard sales team after adjusting its joint sales effort with Pfizer? Report Available: October 7, 2021 The co-promotion and sales deal between PFE and EXAS was once touted as a huge boost that could “permanently alter the trajectory of Cologuard.” That deal has been amended […]
TELA Bio’s Growth Hampered by COVID; OviTex Adoption Will Increase (TELA)
Research Question: Can TELA Bio navigate the COVID pandemic and challenge the current standard of care to generate meaningful and sustained growth? Companies: ABBV, BDX, IART, JNJ, MDT, TELA By: David Franklin Click here to download report (.pdf) Summary of Findings TELA Bio Inc.’s (TELA) expanded commercialization initiative of its tissue reinforcement material, OviTex, […]
Tela Bio Idea Proposal (TELA)
Can Tela Bio navigate the COVID pandemic and challenge the current standard-of-care to generate meaningful and sustained growth? Report Available: August 30, 2021 Blueshift’s ongoing research found TELA helping to drive the early stages of a shift in the medical community from using plastic polypropylene to natural materials for hernia and abdomen wall repair. […]
Sientra on Track for Steady Gains in Highly Competitive Market (SIEN)
Research Question: Can Sientra’s new leadership continue to drive share gains, challenge the industry giants, and stay ahead of emerging competition? Companies: ABBV, ESTA, JNJ, SIEN By: David Franklin Click here to download report (.pdf) Summary of Findings Sientra Inc. (SIEN), a manufacturer of breast implants and tissue expanders recently experienced C-suite changes […]
Aurinia Pharmaceuticals Idea Proposal (AUPH)
Will Aurinia’s launch of Lupkynis withstand the challenges of COVID, competition, and the existing standard-of-care to attain significant sales success? Report Available: July 29, 2021 Blueshift’s initial research found AUPH in the early launch stage of its new drug, Lupkynis for the treatment of lupus nephritis (LN). Lupkynis’ approval came on the heels of […]
Sientra Idea Proposal (SIEN)
Can Sientra’s new leadership continue to drive share gains, challenge the industry giants, and stay ahead of emerging competition? Report Available: July 7, 2021 Blueshift’s initial research found SIEN not only navigating the post-COVID-19 reconstructive and aesthetic breast surgery restart, but also dealing with significant C-suite leadership changes. SIEN has replaced its CEO, promoted […]
Medtronic Losing; Dexcom, Abbott, Insulet Winning in the Diabetes Market (MDT, DXCM, ABT, PODD)
Research Question: Are any of the diabetes wearables market’s key players setting themselves apart and gaining significant share? Companies: ABT, DXCM, MDT, MNKD, PODD, SENS, TNDM By: David Franklin Click here to download report (.pdf) Summary of Findings The diabetes wearable market is growing and its key device providers are secure in their […]
CGM & Insulin Pump Market Idea Proposal
Are any of the diabetes wearables market’s key players setting themselves apart and gaining significant share? Report Available: June 3, 2021 Blueshift’s ongoing research found the continues glucose monitoring (CGM) and insulin pump market experiencing strong and increasing demand despite the negative impact and volatility the COVID-19 pandemic has had on other medical device […]
Reimbursement Key for EDAP & Profound to Challenge Standard of Care (EDAP, PROF)
Research Question: Will EDAP’s and Profound Medical’s minimally invasive prostate cancer treatments significantly challenge the standard of care of surgery and radiation? Companies: EDAP, PROF By: David Franklin Click here to download report (.pdf) Summary of Findings High-intensity focused ultrasound (HIFU) for the treatment of prostate cancer will challenge the standard of care—radical prostatectomy […]
Copyright © 2015 Blueshift Research, LLC. All rights reserved.
